ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement

ERS Genomics Limited and IRBM, announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS’ CRISPR/Cas9 patent portfolio.